National Bank of Canada’s Oncolytics Biotech ONCY Stock Holding History

National Bank of Canada’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.9K	Hold	24,542	–	–	﹤0.01%	2166
2025 Q4	$21.7K	Hold	24,542	–	–	﹤0.01%	2135
2025 Q3	$33.9K	Sell	24,542 -122	-0.5%	-$137	﹤0.01%	2039
2025 Q2	$17.3K	Buy	24,664 +20,001	+429%	+$10.6K	﹤0.01%	2214
2025 Q1	$2.57K	Sell	4,663 -59,816	-93%	-$43.7K	﹤0.01%	2475
2024 Q4	$59.7K	Buy	64,479 +42,955	+200%	+$44.7K	﹤0.01%	1888
2024 Q3	$18.7K	Sell	21,524 -173	-0.8%	-$170	﹤0.01%	1957
2024 Q2	$21.4K	Buy	21,697 +10,000	+85%	+$10.9K	﹤0.01%	1954
2024 Q1	$13.4K	Buy	11,697 +7,958	+213%	+$8.89K	﹤0.01%	2113
2023 Q4	$4.91K	Buy	3,739 +21	+0.6%	+$33	﹤0.01%	2311
2023 Q3	$7.67K	Sell	3,718 -1,052	-22%	-$2.57K	﹤0.01%	2263
2023 Q2	$12.2K	Buy	4,770 +1,262	+36%	+$2.1K	﹤0.01%	2130
2023 Q1	$4.2K	Hold	3,508	–	–	﹤0.01%	2330
2022 Q4	$5.67K	Hold	3,508	–	–	﹤0.01%	2303
2022 Q3	$4K	Hold	3,508	–	–	﹤0.01%	2392
2022 Q2	$3K	Hold	3,508	–	–	﹤0.01%	2547
2022 Q1	$6K	Sell	3,508 -1,000	-22%	-$1.68K	﹤0.01%	2514
2021 Q4	$6K	Buy	+4,508	New	+$8.33K	﹤0.01%	2500

Other funds holding ONCY

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SFP

Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return

Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

EFG

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

National Bank of Canada's ONCY Position: Q1 2026 in Review

National Bank of Canada held its Oncolytics Biotech (ONCY) position steady in Q1 2026 at 24,542 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

National Bank of Canada first reported a position in ONCY in Q4 2021 and has held it in 18 quarters since. The position peaked at $59.7K in Q4 2024. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

National Bank of Canada held 24,542 shares of Oncolytics Biotech worth $20.9K as of Q1 2026.
National Bank of Canada left its Oncolytics Biotech share count unchanged in Q1 2026.
Oncolytics Biotech made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2166 holding.
National Bank of Canada first reported a position in Oncolytics Biotech in Q4 2021 and has held it in 18 quarters since.
National Bank of Canada's Oncolytics Biotech position peaked at $59.7K in Q4 2024.
59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.